ACLX Latest Headlines

Gilead extends Arcellx tender offer again

at seekingalpha.com (Fri, 17-Apr 9:17 AM)

Gilead's $7.8 Billion Deal for Arcellx Puts Spotlight on Anito-cel and Multiple Myeloma Breakthroughs

Market Chameleon (Mon, 23-Feb 9:53 AM)

Gilead’s $7.8B Arcellx Buyout Rides on Anito-cel’s FDA Momentum and Cell Therapy Potential

Market Chameleon (Mon, 23-Feb 7:05 AM)